BrainHQ selected for NIH-funded Study for Long Covid Cognitive Issues
SAN FRANCISCO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- As announced by the US National Institutes of Health (NIH), BrainHQ is being incorporated into phase 2 clinical trials addressing persistent cognitive issues associated with long Covid.
- SAN FRANCISCO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- As announced by the US National Institutes of Health (NIH), BrainHQ is being incorporated into phase 2 clinical trials addressing persistent cognitive issues associated with long Covid.
- BrainHQ is an online brain exercise program, developed and marketed by Posit Science , and has been shown in hundreds of peer-reviewed studies to improve cognitive function and brain health.
- “We have been working with the lead researchers on this study for many months now,” said Dr. Dr. Henry Mahncke , CEO of Posit Science.
- RECOVER-NEURO will examine interventions for cognitive dysfunction related to long COVID, including brain fog, memory problems, and difficulty with attention, thinking clearly, and problem solving.